The recall was issued for several products as a result of manufacturing deviations that "may lead to products of unacceptable quality, and it is not possible to rule out patient risks resulting from use of these products.

Thousands of cases of ophthalmic products were voluntarily recalled after a manufacturing deviation identified during an inspection from the FDA.

The FDA and AvKare have reported a recall of eye care products, including drops and artificial tears, from BRS Analytical Service.